Benitec Biopharma Inc.

NASDAQ: BNTC · Real-Time Price · USD
12.93
0.27 (2.13%)
At close: Aug 15, 2025, 3:59 PM
11.05
-14.54%
After-hours: Aug 15, 2025, 07:55 PM EDT

Benitec Biopharma Cash Flow Statement

Financials in USD. Fiscal year is July - June.
Fiscal Year Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020
Net Income
-26.49M -21.41M -20.86M -21.75M -21.69M -21.81M -20.42M -19.56M -19.97M -18.84M -18.26M -18.21M -17.14M -17.78M -16.21M -13.88M -12.81M -11.01M -9.85M
Depreciation & Amortization
369K 353K 352K 343K 336K 339K 361K 381K 360K 381K 392K 392K 431K 432K 434K 424K 408K 388K 273K
Stock-Based Compensation
4.43M 2.02M 1.17M 830K 503K 382K 241K 452K 493K 614K 901K 870K 981K 1.02M 867K 634K 412K 265K 183K
Other Working Capital
-661.83K -1.18M -448.91K 242.09K 1.26M 1.32M 1.25M 763.03K 459.03K -199.97K 843K 1.11M -460K 1.56M 192K 8K 1.52M -42K 228K
Other Non-Cash Items
2.14M 1.83M 2.59M 3.8M 3.8M 1.21M 1.21M 3K 841.17K 842.17K 862.17K 847.17K -9K -10K -34K -16K 131K 2.23M 4.32M
Deferred Income Tax
n/a n/a n/a -1.2M -1.2M -1.2M -1.2M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Change in Working Capital
882K -1.94M -74.5K 1.18M 656.5K 3.02M 1.27M 714K 339K -320K 1.27M 1.04M -460K 1.56M 192K 8K 1.17M 755K 1.02M
Operating Cash Flow
-18.67M -21.82M -19.48M -19.47M -20.27M -18.07M -18.54M -18.01M -18.77M -18.16M -15.67M -15.9M -16.2M -14.77M -14.75M -12.83M -10.82M -10.93M -9.7M
Capital Expenditures
-18.56K -191.99K -179.99K -179.99K -180.42K -1K -1K -1K -18.83K -18.83K -18.83K -18.83K 141K 126K -48K -221K -375K -360K -267.91K
Cash Acquisitions
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Purchase of Investments
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Sales Maturities Of Investments
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Investing Acitivies
n/a -12K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a -1.39M -1.39M -1.39M
Investing Cash Flow
-18.57K -191.99K -179.99K -179.99K -180.42K -1K 309.01K 309.01K 297.01K 297.01K -13K -13K 141K 126K -48K -221K -375K 1.03M 1.12M
Debt Repayment
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Common Stock Repurchased
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
56.21M 18.88M 18.92M -5.7M 15.11M 14.96M 14.61M 15.7M -2.18M -2.18M -1.87M n/a -1.58M -1.58M -3.23M -3.23M -1.56M -1.63M -405.75K
Financial Cash Flow
108.01M 79.75M 61.92M 68.18M 27.85M 27.69M 27.34M 15.44M 15.7M 15.7M 16.02M n/a 12.67M 12.67M 22.52M 22.52M 9.93M 9.86M -405.75K
Net Cash Flow
89.49M 57.96M 42.03M 48.44M 7.59M 9.84M 9.33M -1.59M -2.06M -1.78M 820K -15.69M -3.36M -1.68M 8.28M 9.97M 588K 166.64K -9.79M
Free Cash Flow
-18.69M -22.01M -19.66M -19.65M -20.46M -18.07M -18.55M -18.01M -18.79M -18.18M -15.68M -15.92M -16.06M -14.64M -14.8M -13.05M -11.2M -11.29M -9.96M